More Acrux Limited news
Acrux LimitedASX: ACR

Acrux Investor Presentation

Feb 24, 2021 at 11:41 PM EST · Issued by Acrux Limited

Filed with ASX · Feb 24, 2021 at 11:41 PM EST

On 6ix: 6ix.com/news/acrux-investor-presentation

Acrux Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Acrux Limited on 6ix

In the deck

  • Acrux — Investor Presentation (February 2021)13 slidesFeb 25, 2021

Story so far

  • Acrux Ltd Investor Presentation and Full Year ResultsAug 26, 2019

Earlier from Acrux

  • Appendix 4D and Half Year Accounts - for the 31 Dec acFeb 24, 2021
  • Share Purchase Plan Closes OversubscribedFeb 2, 2021
  • Acrux Receives FDA Approval - Generic Testosterone SolutionJan 11, 2021
  • Acrux Ltd Share Purchase Plan Offer BookletJan 7, 2021
  • Acrux Raises $7.8m Via Placement and Announces SPPDec 20, 2020

Later from Acrux

  • Acruxs fourth generic dossier accepted by FDA for reviewApr 15, 2021
  • Acrux confirms patent challengeJun 7, 2021
  • Acrux Receives FDA Approval - Generic Efinaconazole SolutionJun 22, 2021
  • Acrux receives third FDA ANDA approvalJul 27, 2021
  • Appendix 4E and Financial ReportAug 25, 2021
All Acrux news releases↗

Follow Acrux into a list and get an email when it puts out news.

Follow Acrux
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer